Comparative Effectiveness Bill Allows Industry Input Into Study Selection
This article was originally published in The Tan Sheet
Executive Summary
A bill introduced in the House would prevent the government from being the sole director of comparative effectiveness research by setting up an independent institute overseen by a broad array of stakeholders, including industry
You may also be interested in...
Baucus Bill Takes “Patient-Centered” Focus For Comparative Effectiveness
The latest comparative effectiveness legislation from Sen. Max Baucus suggests an approach that might be more welcome to the pharma industry
Baucus Bill Takes “Patient-Centered” Focus For Comparative Effectiveness
The latest comparative effectiveness legislation from Sen. Max Baucus suggests an approach that might be more welcome to the pharma industry
Baucus Bill Takes “Patient-Centered” Focus For Comparative Effectiveness
The latest comparative effectiveness legislation from Sen. Max Baucus suggests an approach that might be more welcome to the pharma industry